ERJ
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gustafson, T
Right arrow Articles by Wester, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gustafson, T
Right arrow Articles by Wester, P.
Eur Respir J 1996; 9: 237-240
Copyright © ERS Journals Ltd 1996

Original Articles

Skeletal muscle magnesium and potassium in asthmatics treated with oral beta 2-agonists

T Gustafson, K Boman, L Rosenhall, T Sandstrom, and PO Wester

Dietary magnesium has been shown to be important for lung function and bronchial reactivity. Interest in electrolytes in asthma has so far mainly been focused upon serum potassium, especially linked to beta 2-agonist treatment. It is known that serum levels of magnesium and potassium may not correctly reflect the intracellular status. We therefore investigated whether asthmatics treated with oral beta 2-agonists had low magnesium or potassium in skeletal muscle and serum, and whether withdrawal of the oral beta 2-agonists would improve the electrolyte levels. Magnesium and potassium levels in skeletal muscle biopsies, serum and urine were analysed in 20 asthmatics before and 2 months after withdrawal of long-term oral beta 2-agonists, and for comparison in 10 healthy subjects. Skeletal muscle magnesium in the asthmatics was lower both before (3.62 +/- 0.69 mmol.100 g-1 (mean +/- SD)) and after (3.43 +/- 0.60 mmol.100 g-1) withdrawal of oral beta 2-agonists compared with the controls (4.43 +/- 0.74 mmol.100 g-1). Skeletal muscle potassium and serum magnesium did not differ between the groups. Serum potassium was significantly lower both before (4.0 +/- 0.2 mmol.L-1) and after (3.9 +/- 0.2 mmol.L-1) the withdrawal of oral beta 2-agonists compared with the control group (4.2 +/- 0.2 mmol.L-1). The asthmatics had lower skeletal muscle magnesium and lower serum potassium than the healthy controls, both with and without oral beta 2-agonists. Whether the findings are related to asthma pathophysiology or treatment is currently being investigated.


This article has been cited by other articles:


Home page
 Br J AnaesthHome page
A. M. Duke, P. M. Hopkins, P. J. Halsall, and D. S. Steele
Mg2+ dependence of Ca2+ release from the sarcoplasmic reticulum induced by sevoflurane or halothane in skeletal muscle from humans susceptible to malignant hyperthermia
Br. J. Anaesth., September 1, 2006; 97(3): 320 - 328.
[Abstract] [Full Text] [PDF]

Home page
 Am J EpidemiolHome page
F. D. Gilliland, K. T. Berhane, Y.-F. Li, D. H. Kim, and H. G. Margolis
Dietary Magnesium, Potassium, Sodium, and Children's Lung Function
Am. J. Epidemiol., January 15, 2002; 155(2): 125 - 131.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
O. S. B. Alamoudi
Electrolyte Disturbances in Patients With Chronic, Stable Asthma : Effect of Therapy
Chest, August 1, 2001; 120(2): 431 - 436.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1996 by the European Respiratory Society.